Solventum (NYSE:SOLV) Now Covered by Analysts at Mizuho

Mizuho started coverage on shares of Solventum (NYSE:SOLV) in a report published on Wednesday morning, Marketbeat.com reports. The brokerage issued a neutral rating and a $70.00 price objective on the stock.

A number of other research firms also recently issued reports on SOLV. Wells Fargo & Company reduced their price target on shares of Solventum from $69.00 to $64.00 and set an “equal weight” rating on the stock in a research note on Friday, August 9th. Wolfe Research began coverage on shares of Solventum in a research note on Thursday, September 26th. They issued a “peer perform” rating on the stock. Piper Sandler upped their target price on shares of Solventum from $71.00 to $75.00 and gave the stock a “neutral” rating in a research note on Friday, November 8th. Morgan Stanley upped their target price on shares of Solventum from $60.00 to $73.00 and gave the stock an “equal weight” rating in a research note on Monday, November 11th. Finally, Stifel Nicolaus began coverage on shares of Solventum in a research note on Tuesday, October 8th. They set a “buy” rating and a $82.00 target price on the stock. One analyst has rated the stock with a sell rating, nine have assigned a hold rating and one has assigned a buy rating to the company’s stock. Based on data from MarketBeat, Solventum presently has a consensus rating of “Hold” and a consensus target price of $68.29.

Solventum Price Performance

Solventum stock opened at $70.26 on Wednesday. The company’s 50 day simple moving average is $70.62 and its 200-day simple moving average is $62.77. Solventum has a 1 year low of $47.16 and a 1 year high of $96.05. The company has a debt-to-equity ratio of 2.45, a current ratio of 1.15 and a quick ratio of 0.83.

Institutional Investors Weigh In On Solventum

A number of large investors have recently modified their holdings of SOLV. Deseret Mutual Benefit Administrators purchased a new stake in shares of Solventum in the 2nd quarter valued at approximately $25,000. Hollencrest Capital Management acquired a new position in shares of Solventum in the 2nd quarter valued at $25,000. Richard W. Paul & Associates LLC acquired a new position in shares of Solventum in the 2nd quarter valued at $26,000. Family Firm Inc. acquired a new position in shares of Solventum in the 2nd quarter valued at $26,000. Finally, Copeland Capital Management LLC acquired a new position in shares of Solventum in the 3rd quarter valued at $26,000.

Solventum Company Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.